9. MORRYSSEY J. “Plasma factor VIIa:Ñ Measurement and potencial clinical significante. Homeostasis. 1996, (26):66-71.
10. KALARIA V, ZAREBA W, MOSS AJ, PANCIO G, MARDER VJ, MORRISSEY JH. Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators. Am J Cardiol. 2000; 85(12):1401-1418.
11. POLI K, TOFLER G, LARSON M, EVANS J, SUTHERLAND P, LIPINSKA I. Association of blood pressure with fibrinolytic potential in the framingham offspring population.Circulation 2000;101;264-269.
12. FOLSON R. Hemostcrtic Risk Factors for Atherothrombotic Disease:An Epidemiologic View.División of Epidemiology, School of Public Health, Unlversfty of Minnesota, Minnsapolis,MN, USA,Tiromb Haemost Schattauer GmbH, Stungan. 2001; 3 (86):366- 73
13. JUNGER R, HEINRICH J, SCHULTE,H, LOO J, ASSMANN G. Coagulation factor VII and the risk of coronary heart disease and healthy men. Arteriosclerosis, Thrombosis, and Vascular Biology. 1997; 17: 1539-1544.
14. COOPER J, MILLER G, BAUER K, MORRISEY J, MEADE T, HOWARTH D, et al. Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease. Circulation 2000;102;2816-2822
15. CRAVERI, G TORNAGHI, R RANIERI, L PAGANARDI, P TORTI, F MARELLI, AND GA MORONI (1990) Factor VII and cardiovascular risk in obese subjects Ann Ital Med Int. 2000 April 1; 5(2): 118-20.